Study challenges concerns over hospital readmission reduction practices

January 15, 2020

DALLAS - Jan. 15, 2020 - A UT Southwestern study is challenging concerns that a federal health policy enacted in 2012 to reduce hospital readmissions leaves patients more vulnerable.

The researchers, whose findings published today in BMJ, poured over nine years' worth of Medicare claims data to report on outcomes of patients who received care in observation units and emergency departments in the 30-day period following hospitalization.

The investigation by UT Southwestern cardiology experts was motivated by a rise in post-hospitalization deaths among heart failure and pneumonia patients targeted in the Hospital Readmissions Reduction Program (HRRP). The program reduces payments to hospitals with excess readmissions.

"Our research results were reassuring. We found that although the use of observation units and the emergency department as avenues of care in the post-hospitalization period has increased in recent years, there was no increase in mortality risk in these settings," says Rohan Khera, M.D., a cardiology fellow at UT Southwestern and lead author for the study.

Khera and his team analyzed inpatient and outpatient Medicare claims from 2008-16. This time frame spanned the announcement and implementation of the HRRP.

During that period, there were 3.7 million hospital admissions for heart failure, 1.6 million hospitalizations for myocardial infarction, and more than 3.2 million for pneumonia among Medicare beneficiaries 65 years of age and older.

The overall post-discharge 30-day mortality rate was 8.7 percent for heart failure, 7.3 percent for acute myocardial infarction, and 8.4 percent for pneumonia.

Patients with heart failure, but not those with acute myocardial infarction or pneumonia, experienced an increase in post-discharge 30-day mortality; however, researchers say this increase preceded the announcement of the program and was concentrated among patients who sought no post-discharge acute care, nearly half of whom had been sent to hospice.

"While observation units and the emergency department were increasingly used as avenues of care in the post-discharge period, there has been no increase in the mortality risk in either setting," explains Khera. "Our findings suggest that some of the increase in mortality may be due to transition of end-of-life care from being in the hospital to the period following hospitalization."

Khera says he's putting that hypothesis to the test in his next study.

His health policy research occurs in collaboration with Harlan Krumholz, M.D., S.M., and other investigators at Yale University and is funded by the National Center for Advancing Translational Sciences of the National Institutes of Health.
About UT Southwestern Medical Center

UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution's faculty has received six Nobel Prizes, and includes 22 members of the National Academy of Sciences, 17 members of the National Academy of Medicine, and 14 Howard Hughes Medical Institute Investigators. The full-time faculty of more than 2,500 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide care in about 80 specialties to more than 105,000 hospitalized patients, nearly 370,000 emergency room cases, and oversee approximately 3 million outpatient visits a year.

UT Southwestern Medical Center

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to